| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| No dividends history available for Candriam Equities L Oncology Fund Class C USD Cap. | |||
Candriam Equities L Oncology Fund Class C USD Cap currently pays no dividends.
- ISIN
- WKN
- Symbol / Exchange
- / XMUN
- Value
- €307.82
- Dividend frequency
- none
- Security Type
- Fund
- Dividend Currency
- -
- Inception date
- Fund size
- €1.5bn
- Ongoing charge (TER)
- 1.94%
- 9 Countries
United States
72.64%Switzerland
8.57%United Kingdom
6.49%Denmark
4.72%Japan
2.41%Germany
2.40%France
1.64%Australia
0.95%China
0.19%
- 1 Sector
Health Care
100.00%
- 67 Holdings
- Eli Lilly and Co7.06%
- AstraZeneca PLC4.87%
- Novartis AG4.01%
- Merck & Co Inc3.65%
- Pfizer Inc3.16%
- AbbVie Inc3.05%
- McKesson Corp3.01%
- Gilead Sciences Inc2.87%
- Candriam Equities L Oncology Fund Class C USD Cap does not currently pay dividends.
- Candriam Equities L Oncology Fund Class C USD Cap does not currently pay dividends. Therefore, the dividend yield is 0%.
- Candriam Equities L Oncology Fund Class C USD Cap does not currently pay dividends.
- The largest sectors of Candriam Equities L Oncology Fund Class C USD Cap are Health Care.
- The largest industries of Candriam Equities L Oncology Fund Class C USD Cap are Biotechnology, Pharmaceuticals, Life Sciences Tools & Services.
- There are currently no known stock splits for Candriam Equities L Oncology Fund Class C USD Cap.
- To date, Candriam Equities L Oncology Fund Class C USD Cap has not paid any dividends.
- In Candriam Equities L Oncology Fund Class C USD Cap, the United States, Switzerland and the United Kingdom are represented as the three largest countries.

